ALZHEIMER DISEASE & ASSOCIATED DISORDERS
Scope & Guideline
Pioneering research on Alzheimer’s and its complexities.
Introduction
Aims and Scopes
- Cognitive Function and Dementia Assessment:
Research that explores various methodologies for assessing cognitive function, including neuropsychological tests and imaging techniques, to better understand dementia progression. - Biomarkers and Pathophysiology:
Studies focusing on identifying biomarkers for Alzheimer's disease and related disorders, as well as understanding the underlying biological mechanisms contributing to neurodegeneration. - Impact of Lifestyle and Environmental Factors:
Investigations into how lifestyle choices, such as physical activity and diet, as well as environmental factors, influence cognitive health and the risk of dementia. - Caregiver Studies and Psychosocial Aspects:
Research examining the burden and quality of life for caregivers of Alzheimer’s patients, and the psychosocial impacts of dementia on individuals and families. - Clinical Interventions and Therapeutics:
Studies investigating various therapeutic approaches, including pharmacological and non-pharmacological interventions, aimed at managing or treating Alzheimer’s disease and related disorders. - Diversity and Health Disparities:
Research that highlights the differences in Alzheimer’s disease prevalence and outcomes among diverse populations, addressing health disparities in care and access.
Trending and Emerging
- Holistic and Multidisciplinary Approaches:
There is an increasing trend towards studies that incorporate multidisciplinary perspectives, including psychological, social, and environmental factors in understanding and managing Alzheimer’s disease. - Prevention and Early Intervention Strategies:
Research focused on identifying early signs of cognitive decline and implementing preventive strategies is gaining prominence, highlighting the importance of early detection and intervention. - Technology in Dementia Care:
The use of technology, including digital health tools and telemedicine, in dementia care and research is on the rise, reflecting a shift towards innovative solutions for patient management and research methodologies. - Cultural and Ethnic Studies in Dementia:
Emerging research is increasingly examining the cultural and ethnic dimensions of dementia care, addressing how cultural factors influence perceptions, diagnosis, and treatment of Alzheimer’s disease. - Neuropsychiatric Symptoms and Behavioral Interventions:
There is heightened interest in exploring neuropsychiatric symptoms associated with dementia and the development of behavioral interventions to manage these symptoms effectively.
Declining or Waning
- Genetic Studies in Alzheimer’s Disease:
Although genetic research remains important, the frequency of publications focusing solely on genetic variants related to Alzheimer’s has decreased, possibly due to a saturation of findings and a shift towards integrative approaches that consider environmental and lifestyle factors. - Animal Models in Alzheimer Research:
There has been a noticeable decline in studies exclusively using animal models to investigate Alzheimer’s disease, indicating a potential shift towards human-centric research and clinical studies. - Traditional Pharmacological Approaches:
The focus on traditional pharmacological treatments for Alzheimer’s disease is waning as researchers increasingly explore alternative and complementary therapies, including lifestyle interventions and holistic approaches.
Similar Journals
REJUVENATION RESEARCH
Unlocking the Secrets of Lifelong VitalityRejuvenation Research is a premier journal dedicated to the advancing field of gerontology and aging research, published by Mary Ann Liebert, Inc. Established in 2000, the journal serves as a pivotal platform for the dissemination of scholarly articles that explore the complex mechanisms of aging and innovative approaches to rejuvenation. With an impact factor reflective of its robust scholarly contributions, the journal currently holds a Q4 ranking in Aging and a Q3 ranking in Geriatrics and Gerontology, showcasing its relevance in the academic community. This periodic publication, welcoming open access submissions, invites researchers, professionals, and students alike to engage with cutting-edge findings that could shape future geriatric practices and enhance quality of life. The journal underscores the importance of interdisciplinary collaboration, encouraging explorations that intersect with biochemistry, genetics, and other vital areas of study. Through its ongoing commitment to high-quality research, Rejuvenation Research remains a critical resource for understanding the biological underpinnings of aging and the strategies to mitigate its effects.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Driving change in understanding and managing Alzheimer's disease.Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, published by WILEY, stands at the forefront of research in the fields of neurology and psychiatry. As an Open Access journal since 2015, it fosters transparency and accessibility in sharing critical knowledge pertaining to the diagnosis, assessment, and monitoring of Alzheimer’s disease and related dementias. With an impressive impact factor reflected in its Q1 rankings in both Neurology (Clinical) and Psychiatry and Mental Health, this journal is recognized for its significant contribution to advancing understanding and improving clinical practices, as evidenced by its Scopus rankings in the top percentiles. Researchers, healthcare professionals, and students are encouraged to engage with the latest findings and methodologies that shape the future of dementia care, enhancing both patient outcomes and the scientific community's response to this pressing health challenge. With its headquarters located in Hoboken, NJ, this journal is a pivotal platform for disseminating high-quality, peer-reviewed research that strives to combat one of the most challenging areas in medicine today.
Alzheimers & Dementia
Bridging neuroscience and clinical practice for better outcomes.Alzheimers & Dementia is a premier journal published by WILEY that focuses on the latest advancements in understanding, diagnosing, and treating Alzheimer's disease and other dementias. With an ISSN of 1552-5260 and an E-ISSN of 1552-5279, this influential journal boasts a commendable impact factor and ranks in the Q1 category across several disciplines, including *Cellular and Molecular Neuroscience*, *Geriatrics and Gerontology*, and *Neurology (Clinical)*. By publishing cutting-edge research, systematic reviews, and innovative clinical trials, Alzheimers & Dementia aims to bridge the gap between basic neuroscience and clinical practice, offering valuable insights into the etiology, epidemiology, and management of dementia-related disorders. The journal is hosted in the United States and operates under a balanced access model, providing essential resources for researchers, healthcare professionals, and students dedicated to tackling the challenges posed by these neurodegenerative diseases. Available online, it plays a pivotal role in shaping current and future research directions in the vibrant field of dementia studies.
JOURNAL OF ALZHEIMERS DISEASE
Advancing the understanding of Alzheimer's disease.Journal of Alzheimer's Disease, published by IOS Press, stands as a pivotal resource in the fight against Alzheimer's and related neurodegenerative disorders. With an ISSN of 1387-2877 and an E-ISSN of 1875-8908, this esteemed journal has evolved since its inception in 1998, providing a vital platform for academic research and clinical practice in the realms of Clinical Psychology, Geriatrics and Gerontology, Neuroscience, and Psychiatry and Mental Health. Ranked in the Q1 category across several disciplines, including Clinical Psychology and Geriatrics, this journal not only highlights significant advancements in understanding Alzheimer's disease but also fosters interdisciplinary dialogue among researchers, healthcare professionals, and policymakers. Boasting robust Scopus rankings—such as 49th in Clinical Psychology and 29th in Geriatrics—this journal is committed to disseminating high-quality research that informs both therapeutic strategies and public health initiatives. The Journal of Alzheimer's Disease is an essential resource for anyone dedicated to exploring the complexities of cognitive decline and enhancing care for affected individuals.
Journal of Alzheimers Disease Reports
Transforming Understanding of DementiaJournal of Alzheimer's Disease Reports, published by IOS PRESS, is an essential open-access platform dedicated to advancing research in the fields of clinical psychology, geriatrics, gerontology, neuroscience, and psychiatry. Since its inception in 2017, this journal has rapidly gained recognition, achieving a commendable status reflected in its 2023 category quartiles, notably ranking Q2 in Clinical Psychology and Psychiatry and Mental Health. With a sustained commitment to disseminating high-quality research and facilitating collaboration among scientists, the journal offers insights into the critical aspects of Alzheimer's disease and related cognitive disorders. Given its positions in the Scopus ranks, it serves as a crucial resource for academics and practitioners alike, empowering them to contribute effectively to the ongoing discourse in cognitive health. The journal embraces open access, ensuring that all research findings are freely available to the global community, thereby enhancing visibility and engagement. With a focus on fostering innovation and knowledge transfer, Journal of Alzheimer's Disease Reports is poised to make an enduring impact in the field of dementia research.
AGING NEUROPSYCHOLOGY AND COGNITION
Championing research for a brighter cognitive future.AGING NEUROPSYCHOLOGY AND COGNITION, published by ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD, is a leading scholarly journal that spans the interdisciplinary fields of psychology, neuropsychology, and gerontology. With a strong focus on understanding aging processes and cognitive function, this journal serves as a critical platform for researchers, clinicians, and students dedicated to advancing knowledge in the realm of cognitive aging. The journal, established in 1994, presents high-quality research articles, comprehensive reviews, and innovative studies that contribute to the discourse surrounding mental health and aging. Notably, it has been recognized with a 2023 Q2 ranking in Experimental and Cognitive Psychology and Neuropsychology categories, reflecting its significant impact within these domains. The journal includes open access options, making it widely accessible to a global audience. Researchers interested in the latest findings and theoretical developments in aging neuropsychology will find this journal an invaluable resource, further enhanced by its robust Scopus rankings and commitment to academic excellence through 2024 and beyond.
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY
Connecting research and practice in geriatric mental health.JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, published by SAGE PUBLICATIONS INC, is a premier academic journal dedicated to advancing the understanding of mental health issues and neurological disorders in the aging population. With an established presence since 1988, this journal stands out in the fields of Geriatrics, Gerontology, Neurology, and Psychiatry, currently positioned in the Q2 category based on 2023 metrics, reflecting its influence and academic rigor. The journal is indexed in major databases and is highly regarded for its contributions, as evidenced by its strong Scopus rankings. It serves as an essential resource for researchers, clinicians, and students, offering insightful articles that explore the complex interplay between aging, mental health, and neurological conditions. Although it does not provide open access, it continues to be a vital source of scholarly knowledge for those dedicated to enhancing the well-being of the elderly population.
AGING & MENTAL HEALTH
Exploring the Nexus of Aging and Mental Well-beingAGING & MENTAL HEALTH, published by Routledge Journals, Taylor & Francis Ltd, is a leading academic journal that focuses on the dynamic intersection of aging and mental health, critically addressing issues pertinent to geriatric psychology and psychiatry. Established in 1997, this journal covers a wide range of topics including mental health disorders in older populations, cognitive decline, and social implications of aging. With an impressive reputation, it currently ranks in the Q1 category in Geriatrics and Gerontology, Gerontology, and Psychiatry and Mental Health, showcasing its significant contribution to these fields. The journal is recognized for its high-quality, peer-reviewed research and holds esteemed positions in Scopus rankings, emphasizing its relevance and impact in psychiatric nursing and gerontology. While it does not offer open access, AGING & MENTAL HEALTH remains a vital resource for researchers, professionals, and students dedicated to advancing our understanding of mental health in the aging population.
SCHIZOPHRENIA BULLETIN
Transforming psychiatric research with groundbreaking insights.SCHIZOPHRENIA BULLETIN, published by Oxford University Press, stands as a leading journal in the field of psychiatry and mental health, particularly focusing on the complexities of schizophrenia. Established in 1973, this esteemed journal covers a wide spectrum of research areas, including clinical findings, neurobiology, epidemiology, and treatment approaches, making it indispensable for researchers and practitioners alike. With its current status in the Q1 category of the psychiatry and mental health disciplines, and a remarkable Scopus rank of #34 out of 567, the journal enjoys a strong impact factor, emphasizing its contribution to advancing knowledge in mental health. Although it operates on a subscription model, the significance of the journal in disseminating groundbreaking research makes it a vital resource for those committed to improving outcomes in schizophrenia. Through its rigorous peer-review process and commitment to high-quality scientific communication, SCHIZOPHRENIA BULLETIN continues to be at the forefront of psychiatric research and discourse.
Cerebral Circulation-Cognition and Behavior
Illuminating the Pathways of Thought and BehaviorCerebral Circulation-Cognition and Behavior is an impactful journal published by Elsevier that focuses on the intersections of cerebral circulation, cognitive function, and behavioral science. Since its establishment in 2020, the journal has provided a vital platform for researchers and professionals in the fields of Behavioral Neuroscience, Biological Psychiatry, and Cognitive Neuroscience. With a current classification in the Q3 quartile across several neuroscience categories and a promising trajectory during its converged years (2020-2024), the journal highlights significant advancements in our understanding of the neural underpinnings of behavior. Although it is not open access, its commitment to quality research makes it an essential resource for anyone engaged in neurological, cognitive, and psychiatric studies. As discoveries in these fields continue to grow, Cerebral Circulation-Cognition and Behavior remains dedicated to disseminating influential findings that bridge the gap between cognition, behavior, and neural health.